Catalent Revenue 2012-2021 | CTLT

Catalent annual/quarterly revenue history and growth rate from 2012 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Catalent revenue for the quarter ending March 31, 2021 was $1.053B, a 38.48% increase year-over-year.
  • Catalent revenue for the twelve months ending March 31, 2021 was $3.757B, a 30.81% increase year-over-year.
  • Catalent annual revenue for 2020 was $3.094B, a 22.89% increase from 2019.
  • Catalent annual revenue for 2019 was $2.518B, a 2.22% increase from 2018.
  • Catalent annual revenue for 2018 was $2.463B, a 18.7% increase from 2017.
Catalent Annual Revenue
(Millions of US $)
2020 $3,094
2019 $2,518
2018 $2,463
2017 $2,075
2016 $1,848
2015 $1,831
2014 $1,828
2013 $1,800
2012 $1,695
2011 $1,532
Catalent Quarterly Revenue
(Millions of US $)
2021-03-31 $1,053
2020-12-31 $911
2020-09-30 $846
2020-06-30 $948
2020-03-31 $761
2019-12-31 $721
2019-09-30 $665
2019-06-30 $726
2019-03-31 $618
2018-12-31 $623
2018-09-30 $552
2018-06-30 $685
2018-03-31 $628
2017-12-31 $606
2017-09-30 $544
2017-06-30 $617
2017-03-31 $533
2016-12-31 $484
2016-09-30 $442
2016-06-30 $532
2016-03-31 $438
2015-12-31 $455
2015-09-30 $423
2015-06-30 $510
2015-03-31 $447
2014-12-31 $456
2014-09-30 $418
2014-06-30 $520
2014-03-31 $453
2013-12-31 $441
2013-09-30 $414
2013-06-30
2013-03-31
2012-06-30
2011-06-30
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $19.419B $3.094B
Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment address the full diversity of the pharmaceutical industry including small molecules, large molecule biologics and consumer health products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development and Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. Catalent, Inc. is headquartered in Somerset, New Jersey.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $95.841B 48.53
Takeda Pharmaceutical (TAK) Japan $52.921B 8.34
Astellas Pharma (ALPMY) Japan $32.041B 22.06
Merck (MKGAF) Germany $26.956B 24.06
Eisai (ESALY) Japan $24.965B 60.56
UCB SA (UCBJF) Belgium $19.921B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.759B 26.15
Ono Pharmaceutical (OPHLF) Japan $11.568B 15.73
Grifols, S.A (GRFS) Spain $10.137B 12.35
Jazz Pharmaceuticals (JAZZ) Ireland $9.883B 12.32
Neurocrine Biosciences (NBIX) United States $8.897B 22.95
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.724B 0.00
IPSEN SA ADR (IPSEY) France $8.449B 0.00
United Therapeutics (UTHR) United States $8.347B 20.59
STADA ARZNEIMI (STDAF) Germany $6.870B 0.00
Evotec AG (EVTCY) Germany $6.870B 139.15
Arrowhead Pharmaceuticals (ARWR) United States $6.864B 0.00
Orion OYJ (ORINY) Finland $6.012B 25.98
Tilray (TLRY) Canada $5.695B 0.00
Recursion Pharmaceuticals (RXRX) United States $5.171B 0.00
Ionis Pharmaceuticals (IONS) United States $5.127B 0.00
Hypermarcas (HYPMY) Brazil $4.325B 17.07
Turning Point Therapeutics (TPTX) United States $2.998B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.985B 0.00
Relay Therapeutics (RLAY) United States $2.962B 0.00
Nektar Therapeutics (NKTR) United States $2.901B 0.00
PTC Therapeutics (PTCT) United States $2.750B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.683B 17.95
Cronos Group (CRON) Canada $2.651B 0.00
Pacira BioSciences (PCRX) United States $2.610B 42.65
Sage Therapeutics (SAGE) United States $2.534B 0.00
Translate Bio (TBIO) United States $2.529B 0.00
Corcept Therapeutics (CORT) United States $2.335B 25.67
Ironwood Pharmaceuticals (IRWD) United States $2.122B 13.23
USANA Health Sciences (USNA) United States $2.077B 15.19
Revolution Medicines (RVMD) United States $2.058B 0.00
Organogenesis Holdings (ORGO) United States $1.916B 41.50
Xencor (XNCR) United States $1.821B 0.00
Indivior (INVVY) United States $1.505B 16.25
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.475B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.462B 9.17
Sundial Growers (SNDL) Canada $1.305B 0.00
Heron Therapeutics (HRTX) United States $1.246B 0.00
AlloVir (ALVR) United States $1.230B 0.00
Vectura Group (VEGPF) United Kingdom $1.215B 0.00
FibroGen (FGEN) United States $1.202B 0.00
Endo (ENDP) Ireland $1.139B 1.84
ImmunoGen (IMGN) United States $1.106B 0.00
ChemoCentryx (CCXI) United States $1.023B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.009B 0.00
VAXART, INC (VXRT) United States $0.982B 0.00
Bioventus (BVS) United States $0.955B 0.00
Zogenix (ZGNX) United States $0.914B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.892B 0.00
Rafael Holdings (RFL) United States $0.874B 0.00
Collegium Pharmaceutical (COLL) United States $0.873B 21.34
Ocular Therapeutix (OCUL) United States $0.864B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.837B 0.00
Silence Therapeutics (SLN) United Kingdom $0.777B 0.00
Aclaris Therapeutics (ACRS) United States $0.768B 0.00
Aerie Pharmaceuticals (AERI) United States $0.738B 0.00
Summit Therapeutics (SMMT) United States $0.736B 0.00
Radius Health (RDUS) United States $0.734B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.727B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.691B 0.00
Trillium Therapeutics (TRIL) Canada $0.684B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.664B 0.00
4D Molecular Therapeutics (FDMT) $0.643B 0.00
Karyopharm Therapeutics (KPTI) United States $0.637B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.581B 14.05
Chinook Therapeutics (KDNY) United States $0.573B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.555B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.522B 0.00
KalVista Pharmaceuticals (KALV) United States $0.501B 0.00
Nanobiotix S.A (NBTX) France $0.471B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.468B 0.00
AVITA Medical (RCEL) United States $0.464B 0.00
Siga Technologies (SIGA) United States $0.464B 7.53
Dipexium Pharmaceuticals (PLXP) United States $0.443B 0.00
Inotiv (NOTV) United States $0.441B 0.00
Esperion Therapeutics (ESPR) United States $0.429B 0.00
Acutus Medical (AFIB) United States $0.418B 0.00
Akebia Therapeutics (AKBA) United States $0.405B 0.00
TherapeuticsMD (TXMD) United States $0.401B 0.00
Molecular Templates (MTEM) United States $0.398B 0.00
Viracta Therapeutics (VIRX) United States $0.388B 0.00
KemPharm (KMPH) United States $0.365B 0.00
Nature's Sunshine Products (NATR) United States $0.352B 15.31
Foghorn Therapeutics (FHTX) United States $0.347B 0.00
Altimmune (ALT) United States $0.346B 0.00
Harpoon Therapeutics (HARP) United States $0.331B 0.00
DURECT (DRRX) United States $0.309B 0.00
Flexion Therapeutics (FLXN) United States $0.307B 0.00
PROFOUND MEDICL (PROF) Canada $0.299B 0.00
Redhill Biopharma (RDHL) Israel $0.294B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.293B 0.00
Taiwan Liposome (TLC) Taiwan $0.289B 0.00
MEI Pharma (MEIP) United States $0.286B 0.00
Jounce Therapeutics (JNCE) United States $0.265B 0.00
Innate Pharma SA (IPHYF) France $0.247B 0.00
Clever Leaves Holdings (CLVR) United States $0.241B 0.00
CTI BioPharma (CTIC) United States $0.224B 0.00
Sierra Oncology (SRRA) United States $0.222B 0.00
Alpine Immune Sciences (ALPN) United States $0.216B 0.00
Xeris Pharmaceuticals (XERS) United States $0.214B 0.00
Jaguar Animal Health (JAGX) United States $0.205B 0.00
Lannett Co Inc (LCI) United States $0.191B 9.81
Oncternal Therapeutics (ONCT) United States $0.186B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.183B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.174B 0.00
Adherex Technologies (FENC) United States $0.172B 0.00
Sigilon Therapeutics (SGTX) $0.168B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.167B 0.00
CASI Pharmaceuticals (CASI) United States $0.164B 0.00
Heat Biologics (HTBX) United States $0.161B 0.00
Ardelyx (ARDX) United States $0.159B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.155B 0.00
Novan (NOVN) United States $0.151B 0.00
4D Pharma (LBPS) United Kingdom $0.150B 0.00
IMV INC (IMV) Canada $0.148B 0.00
Savara (SVRA) United States $0.147B 0.00
Progenity (PROG) United States $0.146B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.145B 0.00
Qilian Holding Group (QLI) China $0.144B 0.00
Calithera Biosciences (CALA) United States $0.143B 0.00
SCYNEXIS (SCYX) United States $0.142B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.142B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.141B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.140B 0.00
Champions Oncology (CSBR) United States $0.140B 520.50
VYNE Therapeutics (VYNE) United States $0.139B 0.00
OptiNose (OPTN) United States $0.138B 0.00
Infinity Pharmaceuticals (INFI) United States $0.135B 0.00
Iterum Therapeutics (ITRM) Ireland $0.133B 0.00
Ainos (AIMD) United States $0.129B 0.00
Aquestive Therapeutics (AQST) United States $0.124B 0.00
Lipocine (LPCN) United States $0.117B 0.00
MediWound (MDWD) Israel $0.112B 0.00
Genocea Biosciences (GNCA) United States $0.111B 0.00
Natural Alternatives (NAII) United States $0.107B 11.14
Concert Pharmaceuticals (CNCE) United States $0.106B 0.00
ProPhase Labs (PRPH) United States $0.105B 0.00
GlycoMimetics (GLYC) United States $0.104B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.099B 0.00
Otonomy (OTIC) United States $0.099B 0.00
Gain Therapeutics (GANX) United States $0.099B 0.00
IsoRay (ISR) United States $0.098B 0.00
XPHYTO Therapeutics (XPHYF) Canada $0.097B 0.00
AIM ImmunoTech (AIM) United States $0.095B 0.00
Aziyo Biologics (AZYO) United States $0.087B 0.00
Aptorum Group (APM) United Kingdom $0.087B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.086B 0.00
India Globalization Capital (IGC) United States $0.086B 0.00
Vivos Therapeutics (VVOS) $0.083B 0.00
Minerva Neurosciences (NERV) United States $0.079B 11.56
Onconova Therapeutics (ONTX) United States $0.079B 0.00
Addex Therapeutics (ADXN) Switzerland $0.078B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.070B 0.00
PolarityTE (PTE) United States $0.065B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.060B 0.00
Nutriband (NTRB) United States $0.057B 0.00
Mannatech (MTEX) United States $0.057B 10.57
Recro Pharma (REPH) United States $0.056B 0.00
Brickell Biotech (BBI) United States $0.054B 0.00
Regulus Therapeutics (RGLS) United States $0.052B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 28.25
Assertio Holdings (ASRT) United States $0.051B 0.00
HANCOCK JAFFE (HJLI) United States $0.051B 0.00
AgeX Therapeutics (AGE) United States $0.050B 0.00
Baudax Bio (BXRX) United States $0.050B 0.00
ElectroCore (ECOR) United States $0.047B 0.00
Biomerica (BMRA) United States $0.044B 0.00
Plus Therapeutics (PSTV) United States $0.041B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.036B 0.00
Can-Fite Biopharma (CANF) Israel $0.035B 0.00
Petros Pharmaceuticals (PTPI) United States $0.030B 0.00
Xenetic Biosciences (XBIO) United States $0.028B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.027B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.027B 0.00
Phio Pharmaceuticals (PHIO) United States $0.025B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.025B 0.00
Midatech Pharma (MTP) United Kingdom $0.024B 0.00
Inhibikase Therapeutics (IKT) United States $0.022B 0.00
JanOne (JAN) United States $0.020B 0.00
China SXT Pharmaceuticals (SXTC) China $0.018B 0.00
Cyanotech (CYAN) United States $0.018B 19.53
SHINECO INC (TYHT) China $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.013B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00